Clinical consequences of upfront pathology review in the randomised PORTEC-3 trial for high-risk endometrial cancer. - Boer, S M de; Wortman, B G; Bosse, T; Powell, M E; Singh, N; Hollema, H; Wilson, G; Chowdhury, M N; Mileshkin, L; Pyman, J (Annals of Oncology, 2018)